Haemonetics (HAE) EPS (Basic) (2009 - 2026)

Haemonetics has reported EPS (Basic) for 18 years, with the latest figure at $0.73 in Q2 2026.

• On a quarterly basis, EPS (Basic) rose 2.77% year-over-year to $0.73 in Q2 2026; TTM through Jun 2026 was $2.12, a 37.47% decrease from a year earlier, with the FY2026 full-year figure at $2.06, down 38.09% from the prior year.
• EPS (Basic) was $0.73 for Q2 2026 at Haemonetics, up from -$0.43 in the prior quarter.
• The five-year high for EPS (Basic) was $1.15 in Q1 2025, with the low at -$0.43 in Q1 2026.
• Average EPS (Basic) over 5 years is $0.6, with a median of $0.65 recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: EPS (Basic) jumped 543.79% in 2022, then slumped 137.02% in 2026.
• Over 5 years, EPS (Basic) stood at $0.65 in 2022, then dropped by 5.63% to $0.62 in 2023, then grew by 21.21% to $0.75 in 2024, then grew by 28.24% to $0.96 in 2025, then declined by 23.97% to $0.73 in 2026.
• The last three EPS (Basic) figures came in at $0.73 (Q2 2026), -$0.43 (Q1 2026), and $0.96 (Q4 2025), per Business Quant data.